Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Continuous Intravenous Infusion of Lidocaine on Postoperative Pulmonary Complications and Prognosis in Emergency Surgical Patients With Intra-abdominal Infection

NCT06304779 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT06304779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Continuous Intravenous Infusion of Lidocaine on Postoperative Pulmonary Complications and Prognosis in Emergency Surgical Patients With Intra-abdominal Infection
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2023
Completion date
November 30, 2027
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal infection, postoperative pulmonary complications